National Institute on Alcohol Abuse and Alcoholism (NIAAA)

11 Protocols (11 Active Accrual of new subjects, 0 Follow-up of previously enrolled subjects)

 04-AA-0072:

Clinical Trial of the Cannabinoid CB1 Receptor Antagonist, SR141716 (Rimonabant), to Reduce Voluntary Ethanol Drinking in Healthy, Non-Treatment Seeking Individuals Who Consume Between 20 and 40 Drinks Per Week

 04-AA-0060:

The Effect of Ethanol on Cerebral Blood Flow as Measured by Functional Magnetic Resonance Imaging and the Development of Conditioned Response to Ethanol Administration

 04-AA-0058:

Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) from Plasma into Brain in Healthy Volunteers

 03-AA-0283:

Influence of Age and Gender on Alcohol Metabolism and Acute Responses

 03-AA-0013:

Brain Activation in Response to Motivational and Affective Stimuli: Pharmacological Manipulations

 01-AA-0141:

Polyunsaturated Fatty Acids and the Neurochemistry of Cardiovascular and Behavioral Responses in Aggressive Alcoholics

 01-AA-0098:

The Effect of Fluoxetine on Measures of Domestic Violence

 01-AA-0090:

Effects of Acute Plasma Tryptophan Depletion on Serotonin Receptor Occupancy and Binding Affinity using PET in Healthy and Alcoholic Human Subjects

 98-AA-0056:

Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Non-Alcoholics

 98-AA-0009:

Screening Evaluation for NIAAA Protocols

 94-AA-0124:

Eye Movements in Alcoholics, Patients with Psychiatric or Neurological Disorders, and Normal Controls

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

Warren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/14/2004